Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?-Reference-Cited by-同舟云学术

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

Published:2008-01-29 Issue:1 Volume:113 Page:67-70
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Russo Antonio,Calò Valentina,Bruno Loredana,Schirò Valentina,Agnese Valentina,Cascio Sandra,Foddai Elena,Fanale Daniele,Rizzo Sergio,Di Gaudio Francesca,Gulotta Eliana,Surmacz Eva,Di Fede Gaetana,Bazan Viviana

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-9906-7.pdf

Reference20 articles.

1. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71

2. Ford D, Easton DF, Stratton M, Breast Cancer linkage Consortium et al (1998) Genetic heterogenicity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676–689

3. Pharoah PD, Antoniou A, Bobrow M et al (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36

4. Antoniou AC, Pharoah PD, Narod S et al (2005) Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 42:602–603

5. Rudkin TM, Hamel N, Galvez M et al (2006) The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations. BMC Med Genet 7:15

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?;Frontiers in Oncology;2024-06-21

2. The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times;International Journal of Molecular Sciences;2023-10-24

3. PATHOLOGICAL SIGNIFICANCE OF CDH1/E-CADHERIN GERMLINE SEQUENCE VARIANTS IN BREAST CANCER PATIENTS;Experimental Oncology;2023-10-11

4. Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?;Critical Reviews in Oncology/Hematology;2023-10

5. Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis;Frontiers in Genetics;2023-02-01